Titania nanotube arrays for local drug delivery: Recent advances and perspectives

Expert Opinion on Drug Delivery

Volumn 12, Issue 1, 2015, Pages 103-127

  Losic, Dusan ^a   Aw, Moom Sinn ^a   Santos, Abel ^a   Gulati, Karan ^a   Bariana, Manpreet ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Drug delivery; Drug release; Drug releasing implants; Electrochemical anodization; Localized drug delivery; Orthopedic implants; Titania nanotube arrays

Indexed keywords

NANOCARRIER; NANOTUBE; POLYMER; TITANIA NANOTUBE; TITANIUM; TITANIUM DIOXIDE NANOPARTICLE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BIOMATERIAL; DELAYED RELEASE FORMULATION; DRUG IMPLANT; MICELLE; TITANIUM DIOXIDE;

BIOCOMPATIBILITY; BONE DEVELOPMENT; BONE DISEASE; BONE INFLAMMATION; BONE REGENERATION; CANCER CHEMOTHERAPY; CARDIOVASCULAR STENT; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL VIABILITY; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CONTROLLED DRUG RELEASE; DENTISTRY; DRUG DELIVERY SYSTEM; ELECTROCHEMICAL ANODIZATION; ELECTROCHEMISTRY; EX VIVO STUDY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LOCALIZED DRUG DELIVERY; NANOENCAPSULATION; NANOFABRICATION; NANOPHARMACEUTICS; NANOTOXICOLOGY; ORTHOPEDIC IMPLANT; OSTEOBLAST; OSTEOMYELITIS; PARTICLE SIZE; REVIEW; SURFACE PROPERTY; THICKNESS; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; DRUG IMPLANT; MICELLE; PHARMACOKINETICS; PROCEDURES;

ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; BIOCOMPATIBLE MATERIALS; CELL DIFFERENTIATION; DELAYED-ACTION PREPARATIONS; DENTISTRY; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; MICELLES; NANOTUBES; OSSEOINTEGRATION; POLYMERS; TITANIUM;

EID: 84919458791     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2014.945418     Document Type: Review

References (158)

1. Jain KK. Drug delivery systems. Humana Press, Springer Science + Business Media, LLC. Humana Press, Tatowa, NJ, USA; 2008. p. 1-50
2. Mainardes RM, Silva LP. Drug deliverysystems: past, present, and future. Curr Drug Targets 2004;5:449-55
3. Drews J. Drug discovery: a hystorical perspective. Science 2000;287:1960-4
4. Fahr A, Liu X. Drug delivery strategies for poorly water-soluble drugs. Expert Opin Drug Deliv 2007;4:403-16
5. Kayser O, Lemke A, Trejo NH. The impact of nanobiotechnology on the development of new drug delivery systems. Curr Pharm Biotechnol 2005;6:3-5
6. Hoffman AS. The origins and evolution of "controlled" drug delivery systems. J Control Release 2008;132:153-63
7. Van D, McGuire T, Langer R. Small scale systems for in vivo drug delivery. Nat Biotechnol 2003;21:1184-91
8. Duncan R. Nanomedicine gets clinical. Nanotoday 2005;8:16-17
9. Wolinsky JB, Colson YL, Grinstaff MW. Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric, films, rods, and wafers. J Control Release 2012;159:14-26
10. Wu P, Grainger DW. Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials 2006;27:2450-67
11. Ainslie KM, Desai TM. Microfabricated implants for applications in therapeutic delivery, tissue engineering, and biosensing. Lab Chip 2008;8:1864-78
12. Zilberman M, Elsner JJ. Antibiotic-eluting medical devices for various applications. J Control Release 2008;130:202-15
13. Tao SL, Desai TA. Microfabricated drug delivery systems: from particles to pores. Adv Drug Deliv Rev 2003;55:315-28
14. Jeon G, Seung Yang Y, Kim JK. Functional nanoporous membranes for drug delivery. J Mater Chem 2012;22:14814-34
15. Gultepe E, Nagesha D, Sridhar S, Amiji M. Nanoporous inorganic membranes or coatings for sustained drug delivery in implantable devices. Adv Drug Deliv Rev 2010;62:305-15
16. Arruebo M, Vilaboa N, Santamaria J. Drug delivery from internally implanted biomedical devices used in traumatology and in orthopedic surgery. Exp Opin Drug Deliv 2010;7:1-15
17. Losic D, Simovic S. Self-ordered nanopore and nanotube platforms for drug delivery. Exp Opin Drug Deliv 2009;6:1363-81
18. Roy P, Berger S, Schmuki P. TiO(2) nanotubes: synthesis and applications. Angew. Chem Int Ed Engl 2011;50:2904-39
19. Zwilling V, Darque-Ceretti E, Boutry-Forveille A, et al. Structure and physicochemistry of anodic oxide films on titanium and TA6V alloy. Surf Interfac Anal 1999;27:629-37
20. Grimes CA. Synthesis and application of highly ordered arrays of TiO2 nanotubes. J Mater Chem 2007;17:1451-7
21. Macak JM, Tsuchiya H, Ghicov A, et al. TiO(2) nanotubes: self-organized electrochemical formation, properties and applications. Curr Opin Solid State Mater Sci 2007;11:3-18
22. Bauer S, Schmuki P, et al. Engineering biocompatible implant surfaces, Part I: materials and surfaces. Prog Mater Sci 2013;58:261-326
23. Brammer KS, Frandsen CJ, Sungho Jin J. TiO2 nanotubes for bone regeneration. Trends Biotechnol 2012;30:315-22
24. Rani S, Roy SC, Paulose M, et al. Synthesis and applications of electrochemically self-assembled titania nanotube arrays. Phys Chem Chem Phys 2010;12:2780-800
25. Gulati K, Aw MS, Findlay D, Losic D. Local drug delivery to the bone by drugreleasing implants: perspectives of nanoengineered titania nanotube arrays. Ther Deliv 2012;3:857-73
26. Aw MS, Kurian M, Losic D. Non-eroding drug-releasing implants with ordered nanoporous and nanotubular structures: concepts for controlling drug release. Biomater Sci 2014;2:10-34
27. Losic D, Velleman L, Kant K, et al. Self ordering electrochemistry: a simple approach for engineering nanopore and nanotube arrays for emerging applications. Aust J Chem 2011;64:294-301
28. Ghicov A, Schmuki P. Self-ordering electrochemistry: a review on growth andfunctionality of TiO2 nanotubes and other self-aligned MOx structures. Chem Commun 2009;20:2791-808.
29. Gulati K, Aw MS, Losic D. Drug-eluting Ti wires with titania nanotube arrays for bone fixation and reduced bone infection. Nanoscale Res Lett 2011;6:571 .
30. Macak JM, Tsuchiya H, Schmuki P. High-aspect-ratio TiO2 nanotubes by anodization of titanium. Angew Chem Int Ed 2005;44(14):2100-2
31. Cai QY, Paulose M, Varghese OK, Grimes CA. The effect of electrolyte composition on the fabrication of selforganized titanium oxide nanotube arrays by anodic oxidation. J Mater Res 2005;20:230-6
32. Prakasam HE, Shankar K, Paulose M, et al. A new benchmark for TiO2 nanotube array growth by anodization. J Phys Chem C 2007;111:7235-41
33. Vasilev K, Poh Z, Kant K, et al. Tailoring the surface functionalities of titania nanotube arrays. Biomaterials 2010;31(3):532-40
34. Allam NK, Grimes CA. Formation of vertically oriented TiO2 nanotube arrays using a fluoride free HCl aqueous electrolyte. J Phys Chem C 2007;111(35):13028-32
35. Paulose M, Peng L, Popat KC, et al. Fabrication of mechanically robust, large area, polycrystalline nanotubular/porous TiO2 membranes. J Membr Sci 2008;319(1-2):199-205
36. Albu SP, Kim D, Schmuki P. Growth of aligned TiO2 bamboo-type nanotubes and highly ordered nanolace. Angew Chem Int Ed Engl 2008;47(10):1916-19
37. Chen B, Lu K. Hierarchically branched titania nanotubes with tailored diameters and branch numbers. Langmuir 2012;28:2937-43
38. Albu SP, Ghicov A, Aldabergenova S, et al. Formation of double-walled TiO2 nanotubes and robust anatase membranes. Adv Mater 2008;20(21):4135-9
39. Oh SH, Finones RR, Daraio C, et al. Growth of nano-scale hydroxyapatite using chemically treated titanium oxide nanotubes. Biomaterials 2005;26(24):4938-43
40. Dey T, Roy P, Fabry B, Schmuki P. Anodic mesoporous TiO2 layer on Ti for enhanced formation of biomimetic hydroxyapatite. Acta Biomater 2011;7:1873-9.
41. Pittrof A, Bauer S, Schmuki P. Micropatterned TiO 2 nanotube surfaces for site-selective nucleation of hydroxyapatite from simulated body fluid. Acta Biomater 2011;7:424-31
42. Smith YR, Sarma B, Mohanty SK, Misra M. Light-assisted anodized TiO2 nanotube arrays. ACS Appl Mater Interfaces 2012;4(11):5883-90
43. Neupane MP, Park IS, Bae TS, Lee MH. Sonochemical assisted synthesis of nanostructured titanium oxide by anodic oxidation. J Alloys Compound 2013;581:418-22
44. Matsuno H, Yokoyama A, Watari F, et al. Biocompatibility and osteogenesis of refractory metal implants, titanium, hafnium, niobium, tantalum and rhenium. Biomaterials 2001;22:1253-62
45. Popat KC, Leoni L, Grimes CA, Desai TA. Influence of engineered titania nanotubular surfaces on bone cells. Biomaterials 2007;28:3188-97.
46. Smith BS, Yoriya S, Grissom L, et al. Hemocompatibility of titania nanotube arrays. J Biomed Mater Res Part A 2010;95A:350-60
47. Swami N, Cui Z, Nair LS. Titania nanotubes: novel nanostructures for improved osseointegration. J Heat Transfer 2010;133:034002-8
48. Bjursten LM, Rasmusson L, Oh S, et al. Titanium dioxide nanotubes enhance bone bonding in vivo. J Biomed Mater Res 2010;92A:1218-24
49. Popat KC, Eltgroth M, LaTempa TJ, et al. Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibioticloaded titania nanotubes. Biomaterials 2007;28:4880-8
50. Popat KC, Eltgroth M, La Tempa TJ, et al. Titania nanotubes: a novel platform for drug-eluting coatings for medical implants. Small 2007;3:1878-81
51. Burns K, Yao C, Webster TJ. Increased chondrocyte adhesion on nanotubular anodized titanium. J Biomed Mater Res Part A 2009;88A:561-8
52. Oh S, Daraio C, Chen LH, et al. Significantly accelerated osteoblast cellgrowth on aligned TiO2 nanotubes. J Biomed Mater Res Part A 2006;78A:97-103.
53. Oh S, Jin S. Titanium oxide nanotubes with controlled morphology for enhanced bone growth. Mater Sci Eng C 2006;26:1301-6
54. Oh S, Brammer KS, Li YSJ, et al. Stem cell fate dictated solely by altered nanotube dimension. PNAS 2009;106:2130-5
55. Park J, Bauer S, von der Mark K, Schmuki P. Nanosize and vitality: tiO2 nanotube diameter directs cell fate. Nano Lett 2007;7(6):1686-91
56. Park J, Bauer S, Schlegel KA, et al. TiO2 nanotube surfaces: 15 nm - an optimal length scale of surface topography for cell adhesion and differentiation. Small 2009;5(6):666-71.
57. Brammer KS, Oh S, Frandsen CJ, et al. Nanotube surface triggers increased chondrocyte extracellular matrix production. Mater Sci Eng C 2010;30:518-25
58. Brammer KS, Oh S, Gallagher JO, Jin S. Enhanced cellular mobility guided by TiO2 nanotube surfaces. Nano Lett 2008;8:786-93
59. Smith BS, Yoriya S, Johnson T, Popat KC. Dermal fibroblast and epidermal keratinocyte functionality on titania nanotube arrays. Acta Biomater 2011;7:2686-96
60. Feschet-Chassot E, Raspal V, Awitor OK, et al. Tunable functionality and toxicity studies of titanium dioxide nanotube layers. Thin Solid Films 2011;519(8):2564-8
61. Bauer S, Park J, von der Mark K, Schmuki P. Improved attachment of mesenchymal stem cells on superhydrophobic TiO2 nanotubes. Acta Biomater 2008;4:1576-82
62. Gulati K, Ramakrishnan S, Aw MS, et al. Biocompatible polymer coating of titania nanotube arrays for improved drug elution and osteoblast adhesion. Acta Biomater 2012;8:449-56
63. von Wilmowsky C, Bauer S, Lutz R, et al. In vivo evaluation of anodic TiO (2) nanotubes: an experimental study in the pig. J Biomed Mater Res B Appl Biomater 2009;89B(1):165-71.
64. Bjursten LM, Rasmusson L, Oh S, et al. Titanium dioxide nanotubes enhance bone bonding in vivo. J Biomed Mater Res A 2010;92:1218-24
65. Medical device regulations. Global overview and guiding principles. World Health Organization, WHO, Geneva; 2003
66. ISO/TS 13830:2013, Nanotechnologies- Guidance on voluntary labelling for consumer products containing manufactured nano-objects 2013
67. Tsuji JS, Maynard AD, Howard PC, et al. Research strategies for safety evaluation of nanomaterials. Toxicol Sci 2006;89:42-50
68. Huggins CB, Froehlich JP. High concentration of injected titanium dioxide in abdominal lymph nodes. J Exp Med 1966;124:1099-106
69. Nuevo-Ordóñez Y, Montes-Bayón M, Blanco-González E, et al. Titanium release in serum of patients with different bone fixation implants and its interaction with serum biomolecules at physiological levels. Anal Bioanal Chem 2011;doi: 10.1007/s00216-011-5232-8
70. Li X, Wang L, Fan Y, et al. Biocompatibility and toxicity of nanoparticles and nanotubes. J Nanomater 2012;2012:Article ID 548389
71. Aw MS, Kurian M, Losic D. Polymeric micelles for multidrug delivery and combination therapy. Chem Eur J 2013;19:12586-601 .
72. Shrestha NK, Macak JM, Schmidt-Stein F, et al. Magnetically guided titania nanotubes for site-selective photocatalysis and drug release. Angew Chem Int Ed 2009;48:969-72
73. Aw MS, Addai-Mensah J, Losic D. Polymer micelles for delayed release of therapeutics from drug-releasing Surfaces with nanotubular structures. Macromol Biosci 2012;12:1048-52
74. Cai K, Jiang F, Luo Z, Chen X. Temperature-responsive controlled drug delivery system based on titanium nanotubes. Adv Eng Mater 2010;12:B565-70
75. Aw MS, Addai-Mensah J, Losic D. A multi-drug delivery system with sequential release using titania nanotube arrays. Chem Commun 2012;48:3348-50
76. Aw MS, Simovic S, Addai-Mensah J, Losic D. Polymeric micelles in porous and nanotube materials as a new system for extended delivery of poorly soluble drugs. J Mater Chem 2011;21:7082-9
77. Simovic S, Diener KR, Bachhuka A, et al. Controlled release and bioactivity of the monoclonal antibody rituximab from a porous matrix: a potential in situ therapeutic device. Mater Lett 2014;130:210-14
78. Çal?şkan N, Bayram C, Erdal E, et al. Titania nanotubes with adjustable dimensions for drug reservoir sites and enhanced cell adhesion. Mater Sci Eng C 2014;35:100-5
79. Simovic S, Losic D, Vasilev K. Controlled drug release from porous materials by plasma polymer deposition. Chem Commun 2010;46(8):1317-19
80. Simovic S, Losic D, Vasilev K. Controlled release from porous platforms. Pharm Technol 2011;35(8):68-71
81. Losic D, Cole MA, Dollmann B, et al. Surface modification of nanoporous alumina membranes by plasma polymerization. Nanotechnology 2008;19:245704
82. Gulati K, Atkins GJ, Findlay DM, Losic D. Nano-engineered titanium for enhanced bone therapy. Proc SPIEBiosensing and Nanomedicine VI 2013;doi:10.1117/12.2027151
83. Chen X, Cai K, Fang J, et al. Fabrication of selenium-deposited and chitosancoated titania nanotubes with anticancer and antibacterial properties. Colloids Surf B Biointerfaces 2013;103:149-57
84. Gao A, Hang R, Huang X, et al. The effects of titania nanotubes with embedded silver oxide nanoparticles on bacteria and osteoblasts. Biomaterials 2014;35(13):4223-35
85. Conway D, Cohen JA. Combination therapy in multiple sclerosis. Lancet Neurol 2010;9:299-308
86. Aw MS, Gulati K, Losic D. Controlling drug release from titania nanotube arrays using polymer nanocarriers and biopolymer coating. Biomater Nanobiotech 2011;2:477-84
87. Kalbacova M, Macak JM, Schmidt-Stein F, et al. TiO2 nanotubes: photocatalyst for cancer cell killing. Phys Status Solidi RRL 2008;2:194-6
88. Aw MS, Addai-Mensah J, Losic D. Magnetic-responsive delivery of drugcarriers using titania nanotube arrays. J Mater Chem 2012;22:6561-3
89. Aw MS, Losic D. Ultrasound enhanced release of therapeutics from drugreleasing implants based on titania nanotube arrays. Int J Pharm 2013;443:154-62
90. Bariana M, Aw MS, Moore E, et al. Radiofrequency-triggered release for ondemand delivery of therapeutics from titania nanotube drug-eluting implants. Nanomed 2014;9(8):1263-75.
91. Sirivisoot S, Pareta RA, Webster TJ. A conductive nanostructured polymer electrodeposited on titanium as a controllable, local drug delivery platform. J Biomed Mater Res A 2011;99A(4):586-97
92. Sirivisoot S, Pareta R, Webster TJ. Electrically controlled drug release from nanostructured polypyrrole coated on titanium. Nanotechnology 2011;22(8):085101
93. Sirivisoot S, Yao C, Xiao X, et al. Greater osteoblast functions on multiwalled carbon nanotubes grown from anodized nanotubular titanium for orthopedic applications. Nanotechnology 2007;18(36):365102
94. Sirivisoot S, Webster TJ. Multiwalled carbon nanotubes enhance electrochemical properties of titanium to determine in situ bone formation. Nanotechnology 2008;19(29):295101
95. Porter JR, Ruckh TT, Popat KC. Bone tissue engineering: a review in bone biomimetics and drug delivery strategies. Biotechnol Prog 2009;25(6):1539-60
96. Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science 2000;289:1508-14
97. Ainslie KM, Tao SL, Popat KC, et al. In vitro inflammatory response of nanostructured titania, silicon oxide, and polycaprolactone. J Biomed Mater Res A 2009;91A(3):647-55
98. Aninwene GE, Yao C, Webster TJ. Enhanced osteoblast adhesion to drugcoated anodized nanotubular titanium surfaces. Int.J. Nanomed 2008;3(2):257-64
99. Hunter DJ, Lo GH. The management of osteoarthritis: an overview and call to appropriate conservative treatment. Med Clin North Am 2009;93(1):127-43
100. Hetrick EM, Schoenfisch MH. Reducing implant-related infections: active release strategies. Chem Soc Rev 2006;35(9):780-9
101. Zhang H, Sun Y, Tian A, et al. Improved antibacterial activity and biocompatibility on vancomycin-loaded TiO2 nanotubes: in vivo and in vitro studies. Int J Nanomedicine 2013;8:4379-89
102. Yao C, Webster TJ. Prolonged antibiotic delivery from anodized nanotubular titanium using a co-precipitation drug loading method. J Biomed Mater Res B Appl Biomater 2009;91B(2):587-95
103. Zhao L, Wang H, Huo K, et al. Antibacterial nano-structured titania coating incorporated with silver nanoparticles. Biomaterials 2011;32(24):5706-16
104. Ma M, Kazemzadeh-Narbat M, Hui Y, et al. Local delivery of antimicrobial peptides using self-organized TiO(2) nanotube arrays for peri-implant infections. J Biomed Mater Res A 2012;100A(2):278-85
105. Ercan B, Taylor E, Alpaslan E, Webster TJ. Diameter of titanium nanotubes influences anti-bacterial efficacy. Nanotechnology 2011;22(29):295102
106. Rungsiyakull C, Li Q, Sun G, et al. Surface morphology optimization for osseointegration of coated implants. Biomaterials 2010;31(27):7196-204
107. Swami N, Cui ZW, Nair LS. Titania nanotubes: novel nanostructures for improved osseointegration. J Heat Trans 2011;133(3):034002
108. Kunze J, Mueller L, Macak JM, et al. Time-dependent growth of biomimetic apatite on anodic TiO2 nanotubes. Electrochim Acta 2008;53(23):6995-7003
109. Neupane MP, Park IS, Bae TS, et al. Titania nanotubes supported gelatin stabilized gold nanoparticles for medical implants. J Mater Chem 2011;21(32):12078-82
110. Xin Y, Jiang J, Huo K, et al. Bioactive SrTiO3 nanotube arrays: strontium delivery platform on Ti-based osteoporotic bone implants. ACS Nano 2009;3:3228-34
111. Zhao L, Wang H, Huo K, et al. The osteogenic activity of strontium loaded titania nanotube arrays on titanium substrates. Biomaterials 2013;34(1):19-29
112. Lai M, Cai K, Zhao L, et al. Surface functionalization of TiO2 nanotubes with bone morphogenetic protein 2 and its synergistic effect on the differentiation of mesenchymal stem cells. Biomacromolecules 2011;12(4):1097-105
113. Aw MS, Khalid KA, Gulati K, et al. Characterization of drug-release kinetics in trabecular bone from titania nanotube implants. Int J Nanomedicine 2012;7:4883-92.
114. Jones DB, Broeckmann E, Pohl T, Smith EL. Development of a mechanical testing and loading system for trabecular bone studies for long term culture. Eur Cell Mater 2003;5:48-60
115. Davies CM, Jones DB, Stoddart MJ, et al. Mechanically loaded ex vivo bone culture system Zetos: systems and culture preparation. Eur Cell Mater 2006;11:57-75
116. Xiao J, Zhou H, Zhao L, et al. The effect of hierarchical micro/nanosurface titanium implant on osseointegration inovariectomized sheep. Osteoporos Int 2011;22(6):1907-13
117. Park J-M, Koak J-Y, Jang J-H, et al. Osseointegration of anodized titanium implants coated with fibroblast growth factor-fibronectin (FGF-FN) fusion protein. Int J Oral Maxillofac Implants 2006;21(6):859-66
118. Adell R, Eriksson B, Lekholm U, et al. A long-term follow-up study of osseointegrated implants in the treatment of totally edentulous jaws. Int J Oral Maxillofac Implants 1990;5:347-59
119. Moioli EK, Clark PA, Xin X, et al. Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering. Adv Drug Deliv Rev 2007;59:308-24
120. Shim IK, Chung HJ, Jung MR, et al. Biofunctional porous anodized titanium implants for enhanced bone regeneration. J Biomed Mater Res A 2013. [Epub ahead of print]
121. Hu Y, Cai KY, Luo Z, et al. TiO2 nanotubes as drug nanoreservoirs for the regulation of mobility and differentiation of mesenchymal stem cells. Acta Biomater 2012;8:439-48
122. Lee YH, Bhattarai G, Park IS, et al. Bone regeneration around N-acetyl cysteine-loaded nanotube titanium dental implant in rat mandible. Biomaterials 2013;34:10199-208
123. Demetrescu I, Pirvu C, Mitran V. Effect of nano-topographical features of Ti/ TiO2 electrode surface on cell response and electrochemical stability in artificial saliva. Bioelectrochemistry 2010;79:122-9
124. Ma Q, Mei S, Ji K, et al. Immobilization of Ag nanoparticles/FGF-2 on a modified titanium implant surface and improved human gingival fibroblasts behavior. J Biomed Mater Res A 2011;98:274-86
125. Ma Q, Wang W, Chu PK, et al. Concentration-and time-dependent response of human gingival fibroblasts to fibroblast growth factor 2 immobilized on titanium dental implants. Int J Nanomed 2011;7:1965-76
126. Shokuhfar T, Chang JY, Choi CK, Friedrich C. Survivability of TiO2 nanotubes on the surface of bone screws. Surf Innovations 2013;2:60-8
127. Shokuhfar T, Sinha-Ray S, Sukotjo C, et al. Intercalation of anti-inflammatory drug molecules within TiO2 nanotubes. RSC Adv 2013;3:17380-6
128. Sigwart U, Puel J, Mirkovitch V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987;316:701-6
129. Nabel EG, Braunwald E. A tale of coronary artery disease and myocardial infarction. N Engl J Med 2012;366:54-63
130. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-95
131. Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus- eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80
132. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31
133. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxeleluting stents in routine clinical practice: data from a large twoinstitutional cohort study. Lancet 2007;369:667-78
134. Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-9
135. Sternberg K, Grabow N, Petersen S, et al. Advances in coronary stent technology - Active drug-loaded stent surfaces for prevention of restenosis and improvement of biocompatibility. Curr Pharm Biotechnol 2013;14:76-90
136. Wieneke H, Dirsch O, Sawitowski T, et al. Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits. Catheter Cardiovasc Interv 2003;60:399-407
137. Kollum M, Farb A, Schreiber R, et al. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimuseluting stents in a porcine model of restenosis. Catheter Cardiovasc Interv 2005;64:85-90
138. Fine E, Zhang L, Fenniri H, Webster TJ. Enhanced endothelial cell functions on rosette nanotube-coated titanium vascular stents. Int J Nanomed 2009;4:91-7
139. Peng L, Andrea J, Barczak AJ, et al. Whole genome expression analysis reveals differential effects of TiO2 nanotubes on vascular cells. Nano Lett 2010;10:143-8
140. DiMeco F, Brem H, Weingart J, Olivi A. Gliadel- A new method for the treatment of malignant brain tumors. In: Brown D, editor. Drug delivery systems in cancer therapy. Humana Press, Inc, Totowa, NJ; 2003. p. 215-27
141. Gulati K, Aw M, Losic D. Nanoengineered drug-releasing Ti wires as an alternative for local delivery of chemotherapeutics in the brain. Int J Nanomed 2012;7:2069-76
142. Xiao X, Yang L, Guo M, et al. Biocompatibility and in vitro antineoplastic drug-loaded trial of titania nanotubes prepared by anodic oxidation of a pure titanium. Sci China B Chem 2009;52(12):2161-5
143. So S, Lee K, Schmuki P. Ultrafast growth of highly ordered anodic TiO2 Nanotubes in lactic acid electrolytes. J Am Chem Soc 2012;134(28):11316-18
144. Macak JM, Tsuchiya H, Taveira L, et al. Self-organized nanotubular oxide layers on Ti-6A1-7Nb and Ti-6A1-4V formed by anodization in NH4F solutions. J Biomed Mater Res A 2005;75A(4):928-33
145. Jha H, Hahn R, Schmuki P. Ultrafast oxide nanotube formation on TiNb, TiZr and TiTa alloys by rapid breakdown anodization. Electrochim Acta 2010;55(28):8883-7
146. Liang YQ, Cui ZD, Zhu SL, Yang XJ. Characterization of self-organized TiO2 nanotubes on Ti-4Zr-22Nb-2Sn alloys and the application in drug delivery system. J Mater Sci Mater Med 2011;22(3):461-7
147. Liao J, Lin S, Zhang L, et al. Photocatalytic degradation of methyl orange using a TiO2/Ti mesh electrode with 3D nanotube arrays. ACS Appl Mater Interfaces 2012;4(1):171-7
148. Sun L, Wang X, Li M, et al. Anodic titania nanotubes grown on titanium tubular electrodes. Langmuir 2014;30(10):2835-41
149. Wei W, Berger S, Hauser C, et al. Transition of TiO2 nanotubes to nanopores for electrolytes with very low water contents. Electrochem Commun 2010;12(9):1184-6
150. Kowalski D, Kim D, Schmuki P. TiO2 nanotubes, nanochannels and mesosponge: self-organized formation and applications. Nano Today 2013;8(3):235-64
151. Chennell P, Feschet-Chassot E, Devers T, et al. In vitro evaluation of TiO2 nanotubes as cefuroxime carriers on orthopaedic implants for the prevention of periprosthetic joint infections. Int J Pharm 2013;455(1-2):298-305
152. Huo K, Zhang X, Wang H, et al. Osteogenic activity and antibacterial effects on titanium surfaces modified with Zn-incorporated nanotube arrays. Biomaterials 2013;34(13):3467-78
153. Lai S, Zhang W, Liu F, et al. TiO2 nanotubes as animal drug delivery system and in vitro controlled release. J Nanosci Nanotechnol 2013;13(1):91-7
154. Jia H, Kerr L. Sustained ibuprofen release using composite poly(lactic-coglycolic acid)/titanium dioxide nanotubes from Ti implant surface. J Pharm Sci 2013;102(7):2341-8
155. Koo T-H, Borah J, Xing Z-C, et al. Immobilization of pamidronic acids on the nanotube surface of titanium discs and their interaction with bone cells. Nanoscale Res Lett 2013;8(1):124
156. Kodama A, Bauer S, Komatsu A, et al. Bioactivation of titanium surfaces using coatings of TiO(2) nanotubes rapidly pre-loaded with synthetic hydroxyapatite. Acta Biomater 2009;5(6):2322-30
157. Moon S-H, Lee S-J, Park I-S, et al. Bioactivity of Ti-6Al-4V alloy implants treated with ibandronate after the formation of the nanotube TiO2 layer. J Biomed Mater Res B Appl Biomater 2012;100B(8):2053-9
158. Wei H, Wu S, Feng Z, et al. Increased fibroblast functionality on CNN2-loaded titania nanotubes. Int J Nanomedicine 2012;7:1091-100